Dr. Susan Buchbinder, HPTN 091 investigator, is director of Bridge HIV, a grant-funded research unit housed in the San Francisco Department of Public Health. She is also a clinical professor of Medicine and Epidemiology at UCSF, where she attends at San Francisco General Hospital and teaches in the Training in Clinical Research program.
Pamela Thandeka Tshandu, an HPTN 083-01 and HPTN 084-01 protocol team member, is a community liaison officer at Wits RHI in Johannesburg. Her work focuses on promoting the inclusion of all populations in HIV/AIDS prevention research, ensuring clinical trials are innovative, efficient, and timely.
Dr. Kate MacQueen is a longstanding HPTN Ethics Working Group (EWG) representative supporting HPTN 096, HPTN 083-01, HPTN 084-01, and the Women-at-Risk Scientific Working Group. Dr.
Dr. Jeremy Sugarman, chair of the HPTN Ethics Working Group, is the Harvey M. Meyerhoff Professor of Bioethics and Medicine at the Berman Institute of Bioethics at the Johns Hopkins University in Baltimore. He is an internationally recognized leader in bioethics with expertise in applying empirical methods and evidence-based standards for evaluating and analyzing bioethical issues.